SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-088200
Filing Date
2024-07-31
Accepted
2024-07-31 06:03:19
Documents
13
Period of Report
2024-07-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K idya-20240730.htm   iXBRL 8-K 61554
2 EX-99.1 idya-ex99_1.htm EX-99.1 26344
3 GRAPHIC img107722786_0.jpg GRAPHIC 2663
  Complete submission text file 0000950170-24-088200.txt   219763

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT idya-20240730.xsd EX-101.SCH 30873
15 EXTRACTED XBRL INSTANCE DOCUMENT idya-20240730_htm.xml XML 4723
Mailing Address 5000 SHORELINE CT, STE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 5000 SHORELINE CT, STE 300 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

IRS No.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38915 | Film No.: 241159697
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)